The latest news on available supplies of pediatric and adult formulations of hepatitis A vaccine, inactivated, is mixed. Of the two manufacturers that produce this vaccine for the U.S. market, one reports that it has temporarily ceased taking orders for vials of the vaccine, and the other states that its current production and supply levels are in good shape to handle demand for the product.
That’s according to a Sept. 28 update posted on the CDC’s Current Vaccine Shortages & Immunizations Web page, which further notes that no changes in current recommendations for administration of hepatitis A vaccine are indicated at this time.